Valuation: Bure Equity AB

Capitalization 2.14TCr 232.32Cr 197.38Cr 180.64Cr 170.5Cr 318.03Cr 22TCr 320.84Cr 835.3Cr 11TCr 871.61Cr 853.28Cr 36TCr P/E ratio 2024
4.94x
P/E ratio 2025 -3.91x
Enterprise value 2.11TCr 228.65Cr 194.26Cr 177.78Cr 167.8Cr 313Cr 22TCr 315.76Cr 822.08Cr 10TCr 857.82Cr 839.78Cr 36TCr EV / Sales 2024
4.74x
EV / Sales 2025 -3.91x
Free-Float
70.38%
Yield 2024
0.72%
Yield 2025 1.11%
1 day+1.40%
1 week+8.16%
Current month+8.16%
1 month+28.93%
3 months+42.97%
6 months+15.15%
Current year+17.02%
1 week 272.2
Extreme 272.2
315.8
1 month 226
Extreme 226
315.8
Current year 190.2
Extreme 190.2
315.8
1 year 190.2
Extreme 190.2
331.8
3 years 190.2
Extreme 190.2
421.2
5 years 171.3
Extreme 171.3
489.2
10 years 64.5
Extreme 64.5
489.2
Manager TitleAgeSince
Chief Executive Officer 55 22/04/2013
Director of Finance/CFO 58 01/10/2013
Chief Investment Officer 46 01/01/2019
Director TitleAgeSince
Director/Board Member 56 30/04/2010
Chairman 62 22/04/2013
Director/Board Member 60 04/05/2015
Change 5d. change 1-year change 3-years change Capi.($)
+1.40%+8.16%-5.93%+12.37% 232.32Cr
-1.22%-0.71%+28.34%+65.50% 12TCr
-0.16%-4.82%+31.79%+28.08% 3TCr
-2.04%+0.62%+41.15%+71.02% 2.28TCr
-0.35%-1.06%+42.57%+37.30% 1.8TCr
-1.12%-0.47%+4.44%+9.36% 1.42TCr
-0.82%-2.34%-21.22%-8.16% 1.42TCr
-0.71%+0.63%-4.91%+151.45% 1.28TCr
+0.37%+3.45%-5.44%+53.55% 1.25TCr
+1.37%+2.35%+16.60%+36.49% 1.2TCr
Average -0.33%+0.58%+12.74%+45.70% 2.61TCr
Weighted average by Cap. -0.84%-0.68%+22.74%+54.51%

Financials

2024 2025
Net sales 580.7Cr 63Cr 53Cr 49Cr 46Cr 86Cr 5.95TCr 87Cr 226.37Cr 2.86TCr 236.21Cr 231.24Cr 9.86TCr -460.1Cr -50Cr -42Cr -39Cr -37Cr -68Cr -4.71TCr -69Cr -179.36Cr -2.26TCr -187.15Cr -183.22Cr -7.81TCr
Net income 574.2Cr 62Cr 53Cr 48Cr 46Cr 85Cr 5.88TCr 86Cr 223.84Cr 2.82TCr 233.57Cr 228.65Cr 9.75TCr -467.8Cr -51Cr -43Cr -39Cr -37Cr -69Cr -4.79TCr -70Cr -182.36Cr -2.3TCr -190.29Cr -186.28Cr -7.94TCr
Net Debt -78Cr -8.45Cr -7.18Cr -6.57Cr -6.2Cr -12Cr -797.67Cr -12Cr -30Cr -383.15Cr -32Cr -31Cr -1.32TCr -34Cr -3.68Cr -3.12Cr -2.86Cr -2.7Cr -5.03Cr -347.13Cr -5.08Cr -13Cr -166.74Cr -14Cr -13Cr -575.65Cr
Logo Bure Equity AB
Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
Employees
10
Date Price Change Volume
08/26/08 288.80 kr +1.40% 4,47,017
07/26/07 284.80 kr -4.24% 9,55,059
06/26/06 297.40 kr +4.64% 2,72,269
05/26/05 284.20 kr +1.50% 1,42,684
04/26/04 280.00 kr +4.87% 2,77,141
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB